Heart Test Laboratories
HSCS
7 hedge funds and large institutions have $220K invested in Heart Test Laboratories in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
232% more capital invested
Capital invested by funds: $66.3K → $220K (+$154K)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
40% more funds holding
Funds holding: 5 → 7 (+2)
3.4% more ownership
Funds ownership: 2.18% → 5.58% (+3.4%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$65.3K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$40.6K |
| 3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$35K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$1.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$7.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.51K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.55K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ASW
1
Astoria Strategic Wealth
Conroe,
Texas
| $71K | – | – | – |
|
|
2
Citadel Advisors
Miami,
Florida
| $70.1K | +$65.3K | +18,684 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $43.5K | +$40.6K | +11,599 | New |
|
|
ASN
4
Advisory Services Network
Atlanta,
Georgia
| $31.2K | +$35K | +10,000 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $2.49K | -$2.51K | -718 | -52% |
|
|
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.5K | +$1.4K | +400 | New |
|
|
7
Bank of America
Charlotte,
North Carolina
| $38 | +$3 | +1 | +11% |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$7.4K | -2,625 | Closed |
|
|
9
Osaic Holdings
Scottsdale,
Arizona
| – | -$1.55K | -550 | Closed |
|
HSCS Hedge Fund Activity: Q2 2025 in Review
7 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q2 2025, worth a combined $220K — up 232% from $66.3K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new HSCS positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $65.3K. The largest seller was UBS Group, exiting entirely with an estimated $7.4K sold.
- 7 institutional investors held Heart Test Laboratories (HSCS) as of Q2 2025, up from 5 in Q1 2025.
- Funds reported $220K of Heart Test Laboratories stock for Q2 2025, up 232% quarter-over-quarter.
- 4 funds opened new Heart Test Laboratories positions in Q2 2025 and 2 closed out, a net change of +2 holders.
- The largest Heart Test Laboratories buyer in Q2 2025 was Citadel Advisors, an estimated $65.3K added.
- The largest Heart Test Laboratories seller in Q2 2025 was UBS Group, an estimated $7.4K sold.
Based on aggregated 13F filings for Q2 2025.